Stay updated on Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial
Sign up to get notified when there's something new on the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page.

Latest updates to the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record, replacing the study details with an access-denied message. This indicates the page is inaccessible.SummaryDifference23%

- Check21 days agoChange DetectedThe page now displays the updated revision label v3.7.0, replacing the older v3.6.6. This appears to be a metadata update that does not alter study data or eligibility details.SummaryDifference0.0%

- Check35 days agoChange DetectedThe revision label on the page was updated from v3.6.5 to v3.6.6, indicating an administrative update to the trial details entry.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, indicating an administrative update to the ClinicalTrials.gov page. This change does not modify study content, eligibility criteria, or user-facing information.SummaryDifference0.0%

- Check71 days agoChange DetectedThe study record version was updated from v3.6.3 to v3.6.4, indicating a small documentation update. It does not reflect changes to eligibility, endpoints, or treatment.SummaryDifference0.0%

- Check85 days agoChange DetectedPublications section added with a citation to the Pembrolizumab, Temozolomide and HSPPC-96 vaccine study in newly diagnosed GBM, and a note that entries are auto-filled from PubMed.SummaryDifference0.2%

Stay in the know with updates to Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiation Therapy Combo in Newly Diagnosed GBM Clinical Trial page.